Our Liposomal NAD+, Creatine, and Glutathione are now available at Erewhon
Dosing Protocols and Administration Schedules Typical Lip C protocols involve intramuscular or subcutaneous injection once to three times weekly, with doses ranging from 25 mL depending on concentration and individual tolerance
What the Research Does Not Prove It does not prove safety or effectiveness in humans
Currently available FDA-approved GLP-1 RAs include several monotherapy agents and one combination multi-agonist, the dual GLP-1/GIP agonist tirzepatide (Zheng et al., 2024)
Researchers noted that it is often incorrectly thought, by patients as well as some clinicians, that obesity management medications can be discontinued after achieving initial weight loss
53 Each variant copy was associated with a 42% increased risk for microalbuminuria at long-term follow-up